Targeting tumor cells with bispecific antibodies and T cells
- 30 April 1998
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 53 (1-3) , 77-84
- https://doi.org/10.1016/s0168-3659(97)00239-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Characterization of a Single-chain Antibody to the β-Chain of the T Cell ReceptorPublished by Elsevier ,1995
- New perspectives of C1328-137-mediated T cell costimulationImmunity, 1995
- Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implicationsCancer, 1994
- Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cellsBiochemical Pharmacology, 1994
- Selective Targeting of Malignant Cells with Cytotoxin-Folate ConjugatesJournal of Drug Targeting, 1994
- RAG-1-deficient mice have no mature B and T lymphocytesCell, 1992
- Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis.Proceedings of the National Academy of Sciences, 1991
- Positive and negative selection of an antigen receptor on T cells in transgenic miceNature, 1988
- Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic miceNature, 1988
- Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes.Proceedings of the National Academy of Sciences, 1984